Verseon
Fremont, US
Biotech
Founders & leadership
AP
Adityo PrakashExecutive Officer, Director
DK
David KitaExecutive Officer
EF
Eniko FodorExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$101.4KraisedApr 2019 · 1 investors · Pharmaceuticals
Rule 506(b)$11.8MraisedMay 2015 · 5 investors · Pharmaceuticals
Rule 506(b)$6.5MraisedMay 2015 · 22 investors · Pharmaceuticals
Rule 506(b)$69.8KraisedMay 2015 · 5 investors · Pharmaceuticals
Rule 506(b)$451KraisedMay 2015 · 10 investors · Pharmaceuticals
Rule 506(b)$259.6KraisedMay 2015 · 13 investors · Pharmaceuticals
Rule 506(b)$5.8MraisedMay 2015 · 28 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.